Preliminary report: A serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population

Metabolism: Clinical and Experimental

Volumn 59, Issue 3, 2010, Pages 333-337

  Koh, Sang Back ^a   Park, Jong Ku ^a   Yoon, Jin Ha ^a   Chang, Sei Jin ^a   Oh, Sung Soo ^a   Ryu, So Yeon ^b   Kim, Ki Soon ^b   Lee, Tae Yong ^c  

^a Sung) H   (South Korea)

^b Chosun University   (South Korea)

^c Chungnam National University   (South Korea)

^d Sung) H   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; REPUBLIC OF KOREA;

EID: 76349108809     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.031     Document Type: Article

References (15)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
3. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
4. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
5. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., and Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8 (2006) 264-280
6. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
7. World Health Organization Western Pacific Region International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment, Sydney (2000), Heath Communications Australia Pty Limited
8. Yun J.E., Sull J.W., Lee H.Y., Park E., Kim S., Jo J., et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev 25 (2009) 259-265
9. Yoon S.J., Lee H.S., Lee S.W., Kim S.Y., Cho E.R., Lee S.J., et al. The association between adiponectin and diabetes in the Korean population. Metabolism 57 (2008) 853-857
10. Kim S.M., Cho K.H., and Park H.S. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr J 53 (2006) 247-254
11. Mohan V., Deepa R., Pradeepa R., Vimaleswaran K.S., Mohan A., Velmurugan K., et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 54 (2005) 476-481
12. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 68 (2004) 975-981
13. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
14. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
15. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741